Friday – May 5thSaturday, May 6thSunday, May 7th

08:00 – 13:30 Registration

13:30 – 14:00 Auditorium 1. Opening Ceremony

Jos Maessen (Maastricht), Mike McMullan (Seattle), Roberto Lorusso (Maastricht) – Michel Jacobs (Maastricht) – Centres of Excellence Awards (Michael Heards – ELSO)

14:00-15:15 Auditorium 1. A year in review
Chairs: Jos Maessen (Maastricht), Mike McMullan (Seattle), and Roberto Lorusso (Maastricht)

Best adult VV-ECMO papers.
Thomas Mueller
Regensburg, Germany


Best adult VA-ECMO papers.
Alain Combes
Paris, France


Best pediatric papers.
Peter P. Roeleveld
Leiden, The Netherlands


Best experimental papers.
Xiaotong Hou
Bejing, China


Panel Discussion

15:15- 15:45 Coffee Break

15:45 – 16:15 Auditorium 1. Euro-ELSO Grants Presentations and 2017 winners

Chairs: James Fortenberry (Atlanta, Gerogia) – Leen Vercaemst (Leuven, Belgium)

Characterizing changes in muscle quantity and quality in critically ill patients receiving veno-venous ECMO for severe respiratory failure.
Bronwen Connolly
London, UK

Neuroimaging to evaluate otcomes in neonates following ECMO treatment (NEONET).
Dullipala Anand,
Glasgow, Scotland

Attenuation of ischemia reperfusion injury after ECPR with selective adenosine agonist.
James H. Mehaffey
Charlottesville, USA

Announcement of 2017 Euro-ELSO Research Grants winners


16:15 – 17:15 Auditorium 1. Best Abstracts (6-8 abstracts)

Chairs: Patrick Weerwind (Maastricht, The Netherlands) – Carl Davis (Glasgow, Scotland)

17:15 – 18:15 Auditorium 1. ECMO 2017: where are we and what should industry look at?

Chairs: Bob Bartlett (Ann Arbor, Michigan) – Alois Philipp (Regensburg, Germany)

[testimonial name=”Maximilian Halbe” email=”” srcimages=”/EuroELSO2017/Speakers/Halbe.jpg” company=”Zurich, Switzerland” designation=””]What kind of pumps should we have? One-fits-all or individualized system?[/testimonial] [testimonial name=”Joseph Zwischenberger” email=”” srcimages=”/EuroELSO2017/Speakers/Zwischenberger.jpg” company=”Lexington, Kentucky” designation=””]Are cannulas really improving?[/testimonial] [testimonial name=”Philip De Somer” email=”” srcimages=”/EuroELSO2017/Speakers/DeSomer.jpg” company=”Gent, Belgium” designation=””]The ideal oxygenator: the actual facts and the dream.[/testimonial]

Panel Discussion

18:15 – 19:15 Get together (cocktail reception). Exhibition Area

Presentation of the 5th Edition of the ELSO “Red Book”

20:00 – 20:45 Concert – St. John Church (Vrijthof, Maastricht)

8:30 – 10:00 Auditorium 2. Can we reduce complication in cardiac arrest patients?

Chairs: Giles Peek (New York, NY) – Alain Vuylsteke (Cambridge, UK)

[testimonial name=”Yih-Sharng Chen” email=”” srcimages=”/EuroELSO2017/Speakers/Chen.jpg” company=”Taiwan, Taipei” designation=””]Brain injury and selective brain cooling.[/testimonial]

Left ventricular and pulmonary stasis: the role of LV unloading

[testimonial name=”Federico Pappalardo” email=”” srcimages=”/EuroELSO2017/Speakers/Pappalardo.jpg” company=”Milan, Italy” designation=””]pro:[/testimonial] [testimonial name=”Christof Schmid” email=”” srcimages=”/EuroELSO2017/Speakers/Schmid.jpg” company=”Regensburg, Germany” designation=””]cons:[/testimonial]

Controversies in ECMO flows:

[testimonial name=”Xiaotong Hou” email=”” srcimages=”/EuroELSO2017/Speakers/Hou.jpg” company=”Bejing, China” designation=””]Pulsatile or non-pulsatile flow.[/testimonial] [testimonial name=”Matthias Lubnow” email=”” srcimages=”/EuroELSO2017/Speakers/Lubnow.jpg” company=”Regensburg, Germany” designation=””]High or low flow.[/testimonial] [testimonial name=”Graeme MacLaren” email=”” srcimages=”/EuroELSO2017/Speakers/MacLaren.jpg” company=”Singapore” designation=””]Post-cardiac arrest ECMO patient management: a new science for improvement?[/testimonial]

Panel discussion

08:30 – 10:00 Room A. Pathophysiology issues in VV-ECMO

Chairs: P. Roekaerts (Maastricht, The Netherlands) – A. Oude Lansink-Hartgring (Groningen, The Netherlands)

[testimonial name=”Gernot Marx” email=”” srcimages=”/EuroELSO2017/Speakers/Marx.jpg” company=”Aachen, Germany” designation=””]Ventilator-induced lung injury in ECMO.[/testimonial] [testimonial name=”Antonio Pesenti” email=”” srcimages=”/EuroELSO2017/Speakers/Pesenti.jpg” company=”Milan, Italy” designation=””]My target for lung-protective mechanical ventilation in ECMO patients.[/testimonial] [testimonial name=”Bob Bartlett” email=”” srcimages=”/EuroELSO2017/Speakers/Bartlett.jpg” company=”Ann Arbor, Michigan” designation=””]Low paO2 and arterial saturation: how low can we go?[/testimonial] [testimonial name=”Dinis dos Reis Miranda” email=”” srcimages=”/EuroELSO2017/Speakers/DosReisMiranda.jpg” company=”Rotterdam, The Netherlands” designation=””]Right ventricular dysfunction in ARDS. How to manage it.[/testimonial]

Panel Discussion

08:30 – 10:00 Room B. ECMO in non-cardio-vascular disease patients

Chairs: Ehsan Natour (Maastricht, The Netherlands) – Steve Conrad (Shreveport, Louisiana)

[testimonial name=”Justyna Swol” email=”” srcimages=”/EuroELSO2017/Speakers/Swol.jpg” company=”Kronach, Germany” designation=””]ECMO in trauma.[/testimonial] [testimonial name=”Jose Garcia” email=”” srcimages=”/EuroELSO2017/Speakers/Garcia.jpg” company=”Boston, Massachussets” designation=””]ECMO and lung transplant: Is ambulatory ECMO the right solution?[/testimonial] [testimonial name=”Jos Maessen” email=”” srcimages=”/EuroELSO2017/Speakers/Maessen.jpg” company=”Maastricht, The Netherlands” designation=””]ECMO and lung surgery.[/testimonial] [testimonial name=”Carl Davis” email=”” srcimages=”/EuroELSO2017/Speakers/Davis.jpg” company=”Glasgow, Scotland” designation=””]ECMO and pediatric surgery.[/testimonial] [testimonial name=”Leen Vercaemst” email=”” srcimages=”/EuroELSO2017/Speakers/Vercaemst.jpg” company=”Leuven, Belgium” designation=””]The role of perfusionist in a multidisciplinary and an outside-cardiac surgery world.[/testimonial]

Panel Discussion

10:00 – 10:30 Coffee Break

10:30 – 12:00 Auditorium 2. Is it possible to set up a Randomized Controlled Trial in ECMO?

Chairs: Dan Brodie (NY, NY) – Dirk Donker (Utrecht, The Netherlands)

[testimonial name=”Jan Belohlavek” email=”” srcimages=”/EuroELSO2017/Speakers/Belohlavek.jpg” company=”Prague, Czech Republic” designation=””]What did we learn after almost 100 randomized patients?[/testimonial] [testimonial name=”Thijs Delnoij” email=”” srcimages=”/EuroELSO2017/Speakers/Delnoij.jpg” company=”Maastricht, The Netherlands” designation=””]Designing a multicentre study on ECPR.[/testimonial] [testimonial name=”Shingo Ichiba” email=”” srcimages=”/EuroELSO2017/Speakers/Ichiba.jpg” company=”Tokyo, Japan” designation=””]A large multicenter study in Asia: the Save II Study.[/testimonial] [testimonial name=”Vincent Pellegrino” email=”” srcimages=”/EuroELSO2017/Speakers/Pellegrino.jpg” company=”Sydney, Australia” designation=””]The importance of well-designed study in cardiac arrest: the CHEER study.[/testimonial] [testimonial name=”Alain Combes” email=”” srcimages=”/EuroELSO2017/Speakers/Combes.jpg” company=”Paris, France” designation=””]The SUPERNOVA and EOLIA studies. Is randomizing in respiratory patients easier?[/testimonial]

Panel Discussion

10:30 – 12:00 Room A. Post-Cardiotomy ECMO in neonates/children

Chairs: Dirk Vlasselaers (Leuven, Belgium) – Tim Jones (Birmingham, UK)

[testimonial name=”Jon Smith” email=”” srcimages=”/EuroELSO2017/Speakers/Smith.jpg” company=”Newcastle, UK” designation=””]Post-cardiotomy ECMO in children: trends and outcome.[/testimonial] [testimonial name=”Mike McMullan” email=”” srcimages=”/EuroELSO2017/Speakers/McMullan.jpg” company=”Seattle, Washington” designation=””]What should I do in these situation? Tips and tricks for effective cannulation and ECMO run.[/testimonial] [testimonial name=”Heidi Dalton” email=”” srcimages=”/EuroELSO2017/Speakers/Dalton.jpg” company=”Falls Church” designation=””]How long should I wait for heart recovery, of for other therapies?[/testimonial] [testimonial name=”Bahaaldin Alsoufi” email=”” srcimages=”/EuroELSO2017/Speakers/Alsoufi.jpg” company=”Atlanta, Georgia” designation=””]Post-cardiotomy ECPR rescue in neonates and children. When to do it?[/testimonial] [testimonial name=”Malaika Mendonca” email=”” srcimages=”/EuroELSO2017/Speakers/Mendonca.jpg” company=”Abu Dhabi, UAE” designation=””]A roadmap for improving the results on postcardiotomy ECMO in children:[/testimonial]

Panel Discussion

10:30 – 12:00 Room B. Controversies in VA-ECMO

Chairs: Matthias Lubnow (Regensburg, Germany) – I-wen Wang (Indianapolis, Indiana)

[testimonial name=”Nicholas Cavarocchi” email=”” srcimages=”/EuroELSO2017/Speakers/Cavarocchi.jpg” company=”Philadelphia, Pennsylvania” designation=””]Distal Limb perfusion: always, never, sometimes.[/testimonial] [testimonial name=”Zaheer Babar” email=”” srcimages=”/EuroELSO2017/Speakers/Babar.jpg” company=”Maastricht, The Netherlands” designation=””]ECMO weaning: shunting or not shunting.[/testimonial] [testimonial name=”Karl Träger” email=”” srcimages=”/EuroELSO2017/Speakers/Trager.jpg” company=”Ulm, Germany” designation=””]ECMO and cytokine adsorption – Rational and clinical experiences.[/testimonial] [testimonial name=”Glenn Whitman” email=”” srcimages=”/EuroELSO2017/Speakers/Whitman.jpg” company=”Baltimore” designation=””]Dealing with the Harlequin Syndrome: When and how to act.[/testimonial] [testimonial name=”Fabio Guarracino” email=”” srcimages=”/EuroELSO2017/Speakers/Guarracino.jpg” company=”Pisa, Italy” designation=””]Inotropes, vasoconstrictors or no drugs on ECMO?[/testimonial]

Panel Discussion

12:00 – 13:00 Auditorium 2. ECMO for respiratory distress

Chairs: Thomas Mueller (Regensburg, Germany) – Bill Lynch (Ann Arbor, Michigan)

[testimonial name=”Daniel Herr” email=”” srcimages=”/EuroELSO2017/Speakers/Herr.jpg” company=”Baltimore, Maryland” designation=””]Single Dual-Lumen Cannulation or Double Cannulation for VV-ECMO?[/testimonial] [testimonial name=”Jonas Lindholm” email=”” srcimages=”/EuroELSO2017/Speakers/Lindholm.jpg” company=”Stockholm, Sweden” designation=””]Is the awake patient the right solution?[/testimonial] [testimonial name=”Bob Bartlett” email=”” srcimages=”/EuroELSO2017/Speakers/Bartlett.jpg” company=”Ann Arbor, Michigan” designation=””]Recent insights in regenerative potentials of lung parenchyma: be patient, and lungs will recover![/testimonial]

Panel Discussion

12:00 – 13:00 Room A. Monitoring on ECMO. Part 1

Chairs: Malaika Mendonca (Abu Dhabi, UAE) – Fabio S. Taccone (Bruxelles, Belgium)

[testimonial name=”Mirko Belliato” email=”” srcimages=”/EuroELSO2017/Speakers/Belliato.jpg” company=”Pavia, Italy” designation=””]What’s new in on-line monitoring.[/testimonial] [testimonial name=”Dirk Donker” email=”” srcimages=”/EuroELSO2017/Speakers/Donker.jpg” company=”Utrecht, The Netherlands” designation=””]Echocardiography in ECMO.[/testimonial] [testimonial name=”Aparna Hoskote” email=”” srcimages=”/EuroELSO2017/Speakers/Hoskote.jpg” company=”London, UK” designation=””]Neuromonitoring and neuroassessment.[/testimonial]

12:00 – 13:00 Room B. Designing a better ECMO system: clues for the future.

Chairs: Ludwig von Segesser (Lausanne, Switzerland) – Leen Vercaemst (Leuven, Belgium)

[testimonial name=”Filip De Somer” email=”” srcimages=”/EuroELSO2017/Speakers/DeSomer.jpg” company=”Gent, Belgium” designation=””]View of the clinician.[/testimonial] [testimonial name=”Stefan Breiter” email=”” srcimages=”/EuroELSO2017/Speakers/Breiter.jpg” company=”Wuppertal, Germany” designation=””]View of the engineer.[/testimonial] [testimonial name=”Claudius Diez” email=”” srcimages=”/EuroELSO2017/Speakers/Diez.jpg” company=”Getinge Group” designation=””]View of the industry.[/testimonial]

Panel Discussion

13:00 – 14:00 Lunch Sessions

14:00 – 15:00 Auditorium 2. VA-ECMO in cardiogenic shock

Chairs: Jan Hoorntje (Maastricht, The Netherlands) – Marco Ranucci (Milan, Italy)

[testimonial name=”Ivan Chavez” email=”” srcimages=”/EuroELSO2017/Speakers/Chavez.jpg” company=”Minneapolis, Minnesota” designation=””]ECMO in AMI-cardiogenic shock patients: a must in the cath lab.[/testimonial] [testimonial name=”Pascal Leprince” email=”” srcimages=”/EuroELSO2017/Speakers/Leprince.jpg” company=”Paris, France” designation=””]The role of ECMO in non-AMI cardiogenic shock.[/testimonial] [testimonial name=”Dierk Endeman” email=”” srcimages=”/EuroELSO2017/Speakers/Endeman.jpg” company=”Regensburg, Germany” designation=””]ECMO support for complicated cardiological procedures: an emerging role?[/testimonial]

Panel Discussion

14:00 – 15:00 Room A. Complications in VA-ECMO: how to handle them?

Chairs: Gil Bolotin (Haifa, Israel) – Yih-Sharng Chen (Taipei, Taiwan)

[testimonial name=”Bart Meyns” email=”” srcimages=”/EuroELSO2017/Speakers/Meyns.jpg” company=”Leuven, Belgium” designation=””]Complications in Cannulation.[/testimonial] [testimonial name=”Nick Barret” email=”” srcimages=”/EuroELSO2017/Speakers/Barret.jpg” company=”London, UK” designation=””]Neurologic complications in VA-ECMO patients: Giving up?[/testimonial] [testimonial name=”Bjorn Frenckner” email=”” srcimages=”/EuroELSO2017/Speakers/Frenckner.jpg” company=”Stockholm, Sweden” designation=””]The Harlequin Syndrome: are the heart and brain really suffering?[/testimonial]

Panel Discussion

14:00 – 15:00 Room B. Simulation in ECMO

Chairs: Mark Ogino (Philadelphia, Pennsylvania) – Matteo Di Nardo (Rome, Italy)

[testimonial name=”Michael Broome'” email=”” srcimages=”/EuroELSO2017/Speakers/Broome.jpg” company=”Stockholm, Sweden” designation=””][/testimonial] [testimonial name=”Cara Agerstrand” email=”” srcimages=”/EuroELSO2017/Speakers/Agerstrand.jpg” company=”New York, NY” designation=””][/testimonial]

15:00 – 16:00 Auditorium 2. Complications in VV-ECMO

Chairs : Thijs Delnoy (Maastricht, The Netherlands) – Dan Brodie (New York, NY)

[testimonial name=”Antonio Pesenti” email=”” srcimages=”/EuroELSO2017/Speakers/Pesenti.jpg” company=”Milan, Italy” designation=””]Lung consolidation and prone positioning.[/testimonial] [testimonial name=”Ralf Muellenbach” email=”” srcimages=”/EuroELSO2017/Speakers/Muellenbach.jpg” company=”Kassel, Germany” designation=””]How to optimize VV-ECMO and reduce neurologic events.[/testimonial] [testimonial name=”Alain Combes” email=”” srcimages=”/EuroELSO2017/Speakers/Combes.jpg” company=”Paris, France” designation=””]Are ECMO scores useful to predict outcome in complicated patient?[/testimonial]

Panel Discussion

15:00 – 16:00 Room A. Drug absortion, anticoagulation, and blood management

Chairs: Heidi Dalton (Falls Church, Virginia) – Suneel Pobooni (Leicester, UK)

[testimonial name=”Enno Wilschut” email=”” srcimages=”/EuroELSO2017/Speakers/Wilschut.jpg” company=”Rotterdam, The Netherlands” designation=””]Pharmacology on ECMO: is the pharmacokinetic known?[/testimonial] [testimonial name=”Laurence Lequier” email=”” srcimages=”/EuroELSO2017/Speakers/Lequier.jpg” company=”Edmonton, Canada” designation=””]What’s new in anticoagulation on ECMO.[/testimonial] [testimonial name=”Thomas Mueller” email=”” srcimages=”/EuroELSO2017/Speakers/Mueller.jpg” company=”Regensburg, Germany” designation=””]Hemolysis on ECMO: predictors and management.[/testimonial]

Panel Discussion

15:00 – 16:00 Room B. ECMO in pediatric patients: where are we?

Chairs: Thomas Brogan (Seattle, WA) – Arno van Heijst (Amsterdam, The Netherlands)

[testimonial name=”Ravi Thiagarajan” email=”” srcimages=”/EuroELSO2017/Speakers/Thiagarajan.jpg” company=”Boston, Massachusets” designation=””]Trends and outcomes in VA-ECMO.[/testimonial] [testimonial name=”Melania Bembea” email=”” srcimages=”/EuroELSO2017/Speakers/Bembea.jpg” company=”Baltimore, Maryland” designation=””]Trends and outcome in VV-ECMO.[/testimonial] [testimonial name=”Hanneke Ijsselstijn” email=”” srcimages=”/EuroELSO2017/Speakers/Ijsselstijn.jpg” company=”Rotterdam, The Netherlands” designation=””]Impact on neurocognitive development: the importance of follow-up.[/testimonial]

Panel Discussion

16:00 – 16:30 Coffee Break

16:30 – 17:30 Auditorium 2. Reporting Outcomes and Results in ECMO patients

Chairs: Bob Bartlett (Ann Arbor, Michigan) – Bart Meyns (Leuven, Belgium)

[testimonial name=”Ryan Barbaro” email=”” srcimages=”/EuroELSO2017/Speakers/Barbaro.jpg” company=”Ann Arbor, Michigan” designation=””]ELSO Registry: what’s new.[/testimonial] [testimonial name=”” email=”” srcimages=”/EuroELSO2017/Speakers/None.jpg” company=”” designation=””]Should we have just one Registry? Time for Global and Agreed[/testimonial] [testimonial name=”Steve Conrad” email=”” srcimages=”/EuroELSO2017/Speakers/Conrad.jpg” company=”Shreport, Louisiana” designation=””]Nomenclature in ECMO/ECLS: The ICECLE Project.[/testimonial] [testimonial name=”Sandro Gelsomino” email=”” srcimages=”/EuroELSO2017/Speakers/Gelsomino.jpg” company=”Maastricht, The Netherlands” designation=””]Guidelines on reporting mortality and morbidity in ECMO.[/testimonial]

Panel Discussion

16:30 – 17:30 Room A. Monitoring in ECMO. Part 2/Special Considerations

Chairs: Rodrigo Diaz (Santiago, Chile) – Ibrahim Fawzy (Doha, Qatar)

[testimonial name=”Fabio Taccone” email=”” srcimages=”/EuroELSO2017/Speakers/Taccone.jpg” company=”Bruxelles, Belgium” designation=””]Biomarkers on ECMO: how useful are they?[/testimonial] [testimonial name=”Gail Annich” email=”” srcimages=”/EuroELSO2017/Speakers/Annich.jpg” company=”Toronto, Canada” designation=””]Anticoagulation monitoring.[/testimonial] [testimonial name=”Marco Ranucci” email=”” srcimages=”/EuroELSO2017/Speakers/Ranucci.jpg” company=”Milan, Italy” designation=””]Hemodynamic monitoring.[/testimonial]

Panel Discussion

16:30 – 17:30 Room B. Risk Management and Prevention in ECMO

Chairs: Kostanty Szuldrynski (Cracow, Poland) – Simon Finney (London, UK)

[testimonial name=”David Cooper” email=”” srcimages=”/EuroELSO2017/Speakers/Cooper.jpg” company=”Cincinnati, Ohio” designation=””]How to report complications and misconduct (“the ideal debriefing”)?[/testimonial] [testimonial name=”Matteo Di Nardo” email=”” srcimages=”/EuroELSO2017/Speakers/DiNardo.jpg” company=”Rome, Italy” designation=””]The ideal ECMO Team: periodical simulation and training programs.[/testimonial] [testimonial name=”Leonardo Salazar” email=”” srcimages=”/EuroELSO2017/Speakers/Salazar.jpg” company=”Floridablanca, Colombia” designation=””]The prolonged ECMO support. How to prevent complications.[/testimonial]

Panel Discussion

17:30 – 18:30 Auditorium 2. Weaning from ECMO

Chairs: Nicholas Cavarocchi (Philadelphia, Pennsylvania) Igor Kornilov (Novosibirsk, Russia Federation)

[testimonial name=”Giles Peek” email=”” srcimages=”/EuroELSO2017/Speakers/Peek.jpg” company=”New York, NY” designation=””]Which strategy in VV.[/testimonial] [testimonial name=”Dominik Hoechter” email=”” srcimages=”/EuroELSO2017/Speakers/Hoechter.jpg” company=”Munich, Germany” designation=””]Which strategy in VA.[/testimonial] [testimonial name=”Carlo Banfi” email=”” srcimages=”/EuroELSO2017/Speakers/Banfi.jpg” company=”Geneva, Switzerland” designation=””]If Weaning fails and bridge to nowhere…[/testimonial]

Panel Discussion

17:30 – 18:30 Room A. ECCO2R

Chairs: Alain Combes (Paris, France) – Vincent Pellegrino (Sydney, Australia)

[testimonial name=”Dan Brodie” email=”” srcimages=”/EuroELSO2017/Speakers/Brodie.jpg” company=”NY, NY” designation=””]Update on its use.[/testimonial] [testimonial name=”Alain Combes” email=”” srcimages=”/EuroELSO2017/Speakers/Combes.jpg” company=”Paris, France” designation=””]Pro:[/testimonial] [testimonial name=”Thomas Mueller” email=”” srcimages=”/EuroELSO2017/Speakers/Mueller.jpg” company=”Regensburg, Germany” designation=””]Cons:[/testimonial]

Panel Discussion

17:30 – 18:30 Room B. Post-cardiotomy ECMO in adults: facts, challenges, and new strategies

Chairs: Wolfgang Bhure (Maastricht, The Netherlands) – Michele De Bonis (Milan, Italy)

[testimonial name=”Pascal Leprince” email=”” srcimages=”/EuroELSO2017/Speakers/Leprince.jpg” company=”Paris, France” designation=””]Post-cardiotomy ECMO in adults: the worst results in ECMO?[/testimonial] [testimonial name=”Glenn Whitman” email=”” srcimages=”/EuroELSO2017/Speakers/Whitman.jpg” company=”Baltimore, Maryland” designation=””]ECMO Configuration: Central/Peripheral, Venting/No Venting?[/testimonial] [testimonial name=”Roberto Lorusso” email=”” srcimages=”/EuroELSO2017/Speakers/Lorusso.jpg” company=”Maastricht, The Netherlands” designation=””]Prophylactic ECMO in complex cardiac surgery patients: a new strategy?[/testimonial]

Panel Discussion

18:30 – 22:30 Gala Dinner. Chateau Neercanne (Neercanne, Maastricht)

Bus Transportation. Bus will leave from MECC conference centre from 18:30 on – 500 tickets available- reservation required

08:30 – 09:30 Auditorium 1. ECMO in War Zones

Chairs: Matthew Bacchetta (New York, NY) – Thomas Mueller (Regensburg, Germany)

[testimonial name=”Eric Osborn” email=”” srcimages=”/EuroELSO2017/Speakers/Osborn.jpg” company=”Falls Church, Virginia” designation=””]Peculiar issues for ECMO in war zones.[/testimonial] [testimonial name=”Dan R. Dirnberger” email=”” srcimages=”/EuroELSO2017/Speakers/Dirnberger.jpg” company=”Wilmington, Delaware” designation=””]ECMO Transport.[/testimonial] [testimonial name=”Justyna Swol” email=”” srcimages=”/EuroELSO2017/Speakers/Swol.jpg” company=”Kronach, Germany” designation=””]Only for soldiers or also for local civilians? A new humanitarian action?[/testimonial]

Panel Discussion

09:30 – 10:30 Auditorium 1. Not so common, but emerging indications in ECMO

Chairs: Gail Annich (Toronto, Canada) – Claudio F. Russo (Milan, Italy)

[testimonial name=”Gerry Capatos” email=”” srcimages=”/EuroELSO2017/Speakers/Capatos.jpg” company=”Johannersburg, South Africa” designation=””]ECMO in severe infectious illnesses.[/testimonial] [testimonial name=”Kenneth Palmer” email=”” srcimages=”/EuroELSO2017/Speakers/Palmer.jpg” company=”Stockholm, Sweden” designation=””]ECMO in pregnancy.[/testimonial] [testimonial name=”Sandeep Dewan” email=”” srcimages=”/EuroELSO2017/Speakers/Dewan.jpg” company=”New Delhi, India” designation=””]ECMO in intoxication.[/testimonial] [testimonial name=”Graeme MacLaren” email=”” srcimages=”/EuroELSO2017/Speakers/MacLaren.jpg” company=”Singapore” designation=””]ECMO in septic shock: new evidences?[/testimonial]

Panel Discussion

10:30 – 11:00 Coffee Break

11:00 – 12:00 Auditorium 1. What should I do if….

Chairs: Laurence Lequier (Edmonton, Canada) – Nicholas Barret (London, UK)

[testimonial name=”Christof Schmid” email=”” srcimages=”/EuroELSO2017/Speakers/Schmid.jpg” company=”Regensburg, Germany” designation=””]…..there are thrombi in the heart?[/testimonial] [testimonial name=”Mikael Broman” email=”” srcimages=”/EuroELSO2017/Speakers/Broman.jpg” company=”Stockholm, Sweden” designation=””]…..there is severe pulmonary bleeding or severe desaturation on VV-ECMO?[/testimonial] [testimonial name=”I-wen Wang” email=”” srcimages=”/EuroELSO2017/Speakers/Wang.jpg” company=”Indianapolis, Illinois” designation=””]… post-cardiac arrest ECMO? LV vent or no vent? IABP or not?[/testimonial]

12:00 – 12:30 Auditorium 1. Training and simulation in “fast conditions”

12:30 – 13:00 Auditorium 1. Closing remarks
Jos Maessen (Maastricht), Mike McMullan (Seattle), Roberto Lorusso (Maastricht),
 Jan Belohlavek (Prague)